• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新加坡的脑膜瘤:人口统计学和生物学特征

Meningiomas in Singapore: demographic and biological characteristics.

作者信息

Das A, Tang W Y, Smith D R

机构信息

Department of Neurology, National Neuroscience Institute, Singapore, Republic of Singapore.

出版信息

J Neurooncol. 2000 Apr;47(2):153-60. doi: 10.1023/a:1006484829159.

DOI:10.1023/a:1006484829159
PMID:10982157
Abstract

We sought to determine the relative incidence of meningiomas compared to other central nervous system tumours in an Asian surgical series, as well as the demographic and biological characteristics of these meningiomas. A review of 655 consecutive cases of central nervous system tumours from 583 patients representing the last five years admissions to one hospital in Singapore was undertaken. A total of 33 malignant/atypical tumours from 19 patients and 196 benign meningiomas from 187 patients were identified. Twenty malignant/atypical and 20 benign tumours were selected at random and subjected to histochemical and immunohistochemical analysis using antibodies directed against p53, bax and 3'-DNA hydroxy groups (TUNEL). Meningiomas comprised some 35.2% of all central nervous system tumours with malignant/atypical meningiomas representing 9.2% of meningiomas. Histochemically, necrosis was the predominant finding. However, peri-necrotic areas displayed p53 positivity in 10% of cases and bax positivity in 25% of cases. Apoptotic cells were detected in the peri-necrotic areas in 90% of benign and 75% of malignant/atypical meningiomas. Meningiomas represent the predominant form of central nervous system tumour in the Singaporean population, and aberration of p53 expression is not associated with tumour formation or progression. There was a slight but non-significant reduction in apoptosis in the progression from benign to malignant meningioma, suggesting that in contrast to many other tumour types disruption of cellular apoptosis is not a predominant driving force in Asian meningioma tumourigenesis.

摘要

我们试图确定在一个亚洲手术系列中,脑膜瘤相对于其他中枢神经系统肿瘤的相对发病率,以及这些脑膜瘤的人口统计学和生物学特征。我们回顾了新加坡一家医院过去五年收治的583例患者的655例连续中枢神经系统肿瘤病例。共识别出19例患者的33例恶性/非典型肿瘤和187例患者的196例良性脑膜瘤。随机选择20例恶性/非典型肿瘤和20例良性肿瘤,使用针对p53、bax和3'-DNA羟基(TUNEL)的抗体进行组织化学和免疫组织化学分析。脑膜瘤约占所有中枢神经系统肿瘤的35.2%,其中恶性/非典型脑膜瘤占脑膜瘤的9.2%。组织化学检查发现,坏死是主要表现。然而,坏死周边区域在10%的病例中显示p53阳性,在25%的病例中显示bax阳性。在90%的良性脑膜瘤和75%的恶性/非典型脑膜瘤的坏死周边区域检测到凋亡细胞。脑膜瘤是新加坡人群中枢神经系统肿瘤的主要形式,p53表达异常与肿瘤形成或进展无关。从良性脑膜瘤到恶性脑膜瘤的进展过程中,凋亡略有减少但无统计学意义,这表明与许多其他肿瘤类型不同,细胞凋亡的破坏不是亚洲脑膜瘤肿瘤发生的主要驱动力。

相似文献

1
Meningiomas in Singapore: demographic and biological characteristics.新加坡的脑膜瘤:人口统计学和生物学特征
J Neurooncol. 2000 Apr;47(2):153-60. doi: 10.1023/a:1006484829159.
2
p53 point mutation is rare in meningiomas from Singaporean patients.p53 点突变在新加坡患者的脑膜瘤中较为罕见。
Asian J Surg. 2005 Jan;28(1):7-10. doi: 10.1016/S1015-9584(09)60249-9.
3
Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.儿童颅内脑膜瘤:一项包括MIB-1免疫组织化学的临床病理研究
Pathol Res Pract. 2000;196(3):151-8. doi: 10.1016/S0344-0338(00)80095-3.
4
Immunohistochemical evaluation of erbB-2 and p53 protein expression in benign and atypical human meningiomas.
J Neurooncol. 1996 Feb;27(2):117-26. doi: 10.1007/BF00177474.
5
Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.良性脑膜瘤的复发:增殖指数、BCL2、p53、激素受体及HER2表达的预测价值
Br J Neurosurg. 2011 Dec;25(6):707-13. doi: 10.3109/02688697.2010.522743. Epub 2010 Oct 27.
6
[P53 protein expression and proliferative potential in non-recurrent and recurrent meningiomas].[非复发性和复发性脑膜瘤中P53蛋白表达及增殖潜能]
No To Shinkei. 1996 Aug;48(8):719-25.
7
Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.SPARC的免疫组化表达与脑膜瘤的复发、生存及恶性潜能相关。
APMIS. 2009 Sep;117(9):651-9. doi: 10.1111/j.1600-0463.2009.02516.x.
8
Poly(ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas.聚(ADP - 核糖)聚合酶 -1(PARP1)和p53标记指数与脑膜瘤的肿瘤分级相关。
Folia Neuropathol. 2014;52(2):111-20. doi: 10.5114/fn.2014.43782.
9
[Atypical and malignant intracranial meningiomas].[非典型和恶性颅内脑膜瘤]
Rev Neurol. 2004;38(4):304-10.
10
[Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study].[HER2/neu在脑膜瘤中的表达:一项免疫组织化学和荧光原位杂交研究]
Zhonghua Bing Li Xue Za Zhi. 2010 Mar;39(3):156-60.

引用本文的文献

1
Recurrence/Regrowth in Grade I Meningioma: How to Predict?I级脑膜瘤的复发/再生长:如何预测?
Front Oncol. 2020 Aug 4;10:1144. doi: 10.3389/fonc.2020.01144. eCollection 2020.
2
Genomic and Molecular Characterization of Brain Tumors in Asian and Non-Asian Patients of Los Angeles: A Single Institution Analysis.洛杉矶亚洲和非亚洲患者脑肿瘤的基因组与分子特征:单机构分析
Brain Tumor Res Treat. 2017 Oct;5(2):64-69. doi: 10.14791/btrt.2017.5.2.64. Epub 2017 Oct 31.
3
Atypical Growth Pattern of an Intraparenchymal Meningioma.脑实质内脑膜瘤的非典型生长模式。

本文引用的文献

1
Regulation of p53 downstream genes.p53下游基因的调控
Semin Cancer Biol. 1998;8(5):345-57. doi: 10.1006/scbi.1998.0097.
2
Alteration of bcl-2 and bax expression in embolized meningiomas.栓塞性脑膜瘤中bcl-2和bax表达的改变。
Brain Tumor Pathol. 1998;15(1):13-7. doi: 10.1007/BF02482095.
3
Regulation of Mdm2-directed degradation by the C terminus of p53.p53 羧基末端对 Mdm2 介导的降解的调控。
Case Rep Radiol. 2016;2016:7985402. doi: 10.1155/2016/7985402. Epub 2016 Sep 26.
4
Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation.扩散加权磁共振成像:诊断非典型或恶性脑膜瘤及检测肿瘤去分化
AJNR Am J Neuroradiol. 2008 Jun;29(6):1147-52. doi: 10.3174/ajnr.A0996. Epub 2008 Mar 20.
Mol Cell Biol. 1998 Oct;18(10):5690-8. doi: 10.1128/MCB.18.10.5690.
4
Apoptosis is associated with atypical or malignant change in meningiomas. An in situ labelling and immunohistochemical study.细胞凋亡与脑膜瘤的非典型或恶性变化相关。一项原位标记和免疫组织化学研究。
Histopathology. 1998 Jul;33(1):64-70. doi: 10.1046/j.1365-2559.1998.00440.x.
5
The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.MIB-1、p53及DNA流式细胞术在完全切除的原发性脑膜瘤中的预后意义。
Cancer. 1998 Jun 1;82(11):2262-9.
6
Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas.p53、MDM2蛋白及Ki-67抗原在复发性脑膜瘤中的表达
J Neurooncol. 1998 May;38(1):41-9. doi: 10.1023/a:1005946001915.
7
Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas.MIB-1、p53和bcl-2免疫反应性在脑膜瘤中的预后意义。
Hum Pathol. 1998 Feb;29(2):140-5. doi: 10.1016/s0046-8177(98)90224-6.
8
Proliferation and DNA fragmentation in meningioma subtypes.脑膜瘤亚型中的增殖与DNA片段化
Neuropathol Appl Neurobiol. 1997 Dec;23(6):496-506. doi: 10.1111/j.1365-2990.1997.tb01327.x.
9
Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors.
Neurol Res. 1997 Dec;19(6):623-8. doi: 10.1080/01616412.1997.11740871.
10
Movement of Bax from the cytosol to mitochondria during apoptosis.凋亡过程中Bax从细胞质向线粒体的移动。
J Cell Biol. 1997 Dec 1;139(5):1281-92. doi: 10.1083/jcb.139.5.1281.